Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma

International Consensus Recommendations from the American Gastroenterological Association Symposium

Prateek Sharma, David A. Katzka, Neil Gupta, Jaffer Ajani, Navtej Buttar, Amitabh Chak, Douglas Corley, Hashem El-Serag, Gary W. Falk, Rebecca Fitzgerald, John Goldblum, Frank Gress, David H. Ilson, John M. Inadomi, Ernest J. Kuipers, John P. Lynch, Frank McKeon, David Metz, Pankaj Jay Pasricha, Oliver Pech & 9 others Richard Peek, Jeffrey H. Peters, Alessandro Repici, Stefan Seewald, Nicholas J. Shaheen, Rhonda F. Souza, Stuart J. Spechler, Prashanth Vennalaganti, Kenneth Wang

Research output: Contribution to journalArticle

Abstract

The development of and adherence to quality indicators in gastroenterology, as in all of medicine, is increasing in importance to ensure that patients receive consistent high-quality care. In addition, government-based and private insurers will be expecting documentation of the parameters by which we measure quality, which will likely affect reimbursements. Barrett's esophagus remains a particularly important disease entity for which we should maintain up-to-date guidelines, given its commonality, potentially lethal outcomes, and controversies regarding screening and surveillance. To achieve this goal, a relatively large group of international experts was assembled and, using the modified Delphi method, evaluated the validity of multiple candidate quality indicators for the diagnosis and management of Barrett's esophagus. Several candidate quality indicators achieved >80% agreement. These statements are intended to serve as a consensus on candidate quality indicators for those who treat patients with Barrett's esophagus.

Original languageEnglish (US)
Pages (from-to)1599-1606
Number of pages8
JournalGastroenterology
Volume149
Issue number6
DOIs
StatePublished - Nov 1 2015

Fingerprint

Barrett Esophagus
Adenocarcinoma
Insurance Carriers
Quality of Health Care
Gastroenterology
Documentation
Medicine
Guidelines

Keywords

  • Barrett's Esophagus
  • Barrett's Surveillance
  • Consensus Statements
  • Endoscopic Mucosal Resection
  • Esophageal Adenocarcinoma
  • Gastroesophageal Reflux Disease
  • High-Grade Dysplasia
  • Low-Grade Dysplasia
  • Metastatic Esophageal Adenocarcinoma
  • Prague Criteria
  • Proton Pump Inhibitors
  • Quality Indicators
  • Radiofrequency Ablation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma : International Consensus Recommendations from the American Gastroenterological Association Symposium. / Sharma, Prateek; Katzka, David A.; Gupta, Neil; Ajani, Jaffer; Buttar, Navtej; Chak, Amitabh; Corley, Douglas; El-Serag, Hashem; Falk, Gary W.; Fitzgerald, Rebecca; Goldblum, John; Gress, Frank; Ilson, David H.; Inadomi, John M.; Kuipers, Ernest J.; Lynch, John P.; McKeon, Frank; Metz, David; Pasricha, Pankaj Jay; Pech, Oliver; Peek, Richard; Peters, Jeffrey H.; Repici, Alessandro; Seewald, Stefan; Shaheen, Nicholas J.; Souza, Rhonda F.; Spechler, Stuart J.; Vennalaganti, Prashanth; Wang, Kenneth.

In: Gastroenterology, Vol. 149, No. 6, 01.11.2015, p. 1599-1606.

Research output: Contribution to journalArticle

Sharma, P, Katzka, DA, Gupta, N, Ajani, J, Buttar, N, Chak, A, Corley, D, El-Serag, H, Falk, GW, Fitzgerald, R, Goldblum, J, Gress, F, Ilson, DH, Inadomi, JM, Kuipers, EJ, Lynch, JP, McKeon, F, Metz, D, Pasricha, PJ, Pech, O, Peek, R, Peters, JH, Repici, A, Seewald, S, Shaheen, NJ, Souza, RF, Spechler, SJ, Vennalaganti, P & Wang, K 2015, 'Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: International Consensus Recommendations from the American Gastroenterological Association Symposium', Gastroenterology, vol. 149, no. 6, pp. 1599-1606. https://doi.org/10.1053/j.gastro.2015.08.007
Sharma, Prateek ; Katzka, David A. ; Gupta, Neil ; Ajani, Jaffer ; Buttar, Navtej ; Chak, Amitabh ; Corley, Douglas ; El-Serag, Hashem ; Falk, Gary W. ; Fitzgerald, Rebecca ; Goldblum, John ; Gress, Frank ; Ilson, David H. ; Inadomi, John M. ; Kuipers, Ernest J. ; Lynch, John P. ; McKeon, Frank ; Metz, David ; Pasricha, Pankaj Jay ; Pech, Oliver ; Peek, Richard ; Peters, Jeffrey H. ; Repici, Alessandro ; Seewald, Stefan ; Shaheen, Nicholas J. ; Souza, Rhonda F. ; Spechler, Stuart J. ; Vennalaganti, Prashanth ; Wang, Kenneth. / Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma : International Consensus Recommendations from the American Gastroenterological Association Symposium. In: Gastroenterology. 2015 ; Vol. 149, No. 6. pp. 1599-1606.
@article{cadc0580884b415f8074fc9aeb0a0a9d,
title = "Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: International Consensus Recommendations from the American Gastroenterological Association Symposium",
abstract = "The development of and adherence to quality indicators in gastroenterology, as in all of medicine, is increasing in importance to ensure that patients receive consistent high-quality care. In addition, government-based and private insurers will be expecting documentation of the parameters by which we measure quality, which will likely affect reimbursements. Barrett's esophagus remains a particularly important disease entity for which we should maintain up-to-date guidelines, given its commonality, potentially lethal outcomes, and controversies regarding screening and surveillance. To achieve this goal, a relatively large group of international experts was assembled and, using the modified Delphi method, evaluated the validity of multiple candidate quality indicators for the diagnosis and management of Barrett's esophagus. Several candidate quality indicators achieved >80{\%} agreement. These statements are intended to serve as a consensus on candidate quality indicators for those who treat patients with Barrett's esophagus.",
keywords = "Barrett's Esophagus, Barrett's Surveillance, Consensus Statements, Endoscopic Mucosal Resection, Esophageal Adenocarcinoma, Gastroesophageal Reflux Disease, High-Grade Dysplasia, Low-Grade Dysplasia, Metastatic Esophageal Adenocarcinoma, Prague Criteria, Proton Pump Inhibitors, Quality Indicators, Radiofrequency Ablation",
author = "Prateek Sharma and Katzka, {David A.} and Neil Gupta and Jaffer Ajani and Navtej Buttar and Amitabh Chak and Douglas Corley and Hashem El-Serag and Falk, {Gary W.} and Rebecca Fitzgerald and John Goldblum and Frank Gress and Ilson, {David H.} and Inadomi, {John M.} and Kuipers, {Ernest J.} and Lynch, {John P.} and Frank McKeon and David Metz and Pasricha, {Pankaj Jay} and Oliver Pech and Richard Peek and Peters, {Jeffrey H.} and Alessandro Repici and Stefan Seewald and Shaheen, {Nicholas J.} and Souza, {Rhonda F.} and Spechler, {Stuart J.} and Prashanth Vennalaganti and Kenneth Wang",
year = "2015",
month = "11",
day = "1",
doi = "10.1053/j.gastro.2015.08.007",
language = "English (US)",
volume = "149",
pages = "1599--1606",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma

T2 - International Consensus Recommendations from the American Gastroenterological Association Symposium

AU - Sharma, Prateek

AU - Katzka, David A.

AU - Gupta, Neil

AU - Ajani, Jaffer

AU - Buttar, Navtej

AU - Chak, Amitabh

AU - Corley, Douglas

AU - El-Serag, Hashem

AU - Falk, Gary W.

AU - Fitzgerald, Rebecca

AU - Goldblum, John

AU - Gress, Frank

AU - Ilson, David H.

AU - Inadomi, John M.

AU - Kuipers, Ernest J.

AU - Lynch, John P.

AU - McKeon, Frank

AU - Metz, David

AU - Pasricha, Pankaj Jay

AU - Pech, Oliver

AU - Peek, Richard

AU - Peters, Jeffrey H.

AU - Repici, Alessandro

AU - Seewald, Stefan

AU - Shaheen, Nicholas J.

AU - Souza, Rhonda F.

AU - Spechler, Stuart J.

AU - Vennalaganti, Prashanth

AU - Wang, Kenneth

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The development of and adherence to quality indicators in gastroenterology, as in all of medicine, is increasing in importance to ensure that patients receive consistent high-quality care. In addition, government-based and private insurers will be expecting documentation of the parameters by which we measure quality, which will likely affect reimbursements. Barrett's esophagus remains a particularly important disease entity for which we should maintain up-to-date guidelines, given its commonality, potentially lethal outcomes, and controversies regarding screening and surveillance. To achieve this goal, a relatively large group of international experts was assembled and, using the modified Delphi method, evaluated the validity of multiple candidate quality indicators for the diagnosis and management of Barrett's esophagus. Several candidate quality indicators achieved >80% agreement. These statements are intended to serve as a consensus on candidate quality indicators for those who treat patients with Barrett's esophagus.

AB - The development of and adherence to quality indicators in gastroenterology, as in all of medicine, is increasing in importance to ensure that patients receive consistent high-quality care. In addition, government-based and private insurers will be expecting documentation of the parameters by which we measure quality, which will likely affect reimbursements. Barrett's esophagus remains a particularly important disease entity for which we should maintain up-to-date guidelines, given its commonality, potentially lethal outcomes, and controversies regarding screening and surveillance. To achieve this goal, a relatively large group of international experts was assembled and, using the modified Delphi method, evaluated the validity of multiple candidate quality indicators for the diagnosis and management of Barrett's esophagus. Several candidate quality indicators achieved >80% agreement. These statements are intended to serve as a consensus on candidate quality indicators for those who treat patients with Barrett's esophagus.

KW - Barrett's Esophagus

KW - Barrett's Surveillance

KW - Consensus Statements

KW - Endoscopic Mucosal Resection

KW - Esophageal Adenocarcinoma

KW - Gastroesophageal Reflux Disease

KW - High-Grade Dysplasia

KW - Low-Grade Dysplasia

KW - Metastatic Esophageal Adenocarcinoma

KW - Prague Criteria

KW - Proton Pump Inhibitors

KW - Quality Indicators

KW - Radiofrequency Ablation

UR - http://www.scopus.com/inward/record.url?scp=84945581995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945581995&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2015.08.007

DO - 10.1053/j.gastro.2015.08.007

M3 - Article

VL - 149

SP - 1599

EP - 1606

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 6

ER -